Amre A. Elmaoued, PharmD, PhC, BCPP
University of New Mexico College of Pharmacy, Albuquerque, New Mexico
- 3Articles
- 16.3KReads1
- 2024–2025Active
- 3Collaborators
About
Amre A. Elmaoued, PharmD, PhC, BCPP, is affiliated with the University of New Mexico College of Pharmacy in Albuquerque. The author has published on topics including autism spectrum disorders, metabolic disorders related to antipsychotic use, and posttraumatic stress disorder. Specific subjects addressed include incretin therapies for metabolic consequences, risperidone long-acting injection in autism spectrum and borderline personality disorders, and the use of terazosin for trauma-related nightmares. Elmaoued's work has appeared in Psychiatrist.com between 2024 and 2025.
Publications
Incretin Therapies: A New Tool to Combat Metabolic Consequences of Antipsychotic Use
September 4, 2025
Risperidone Long-Acting Injection Reduced Emergency Visits in a Patient With Comorbid Autism Spectrum and Borderline Personality Disorders
May 1, 2025
1 Read counts for articles published before 2020 may include some non-human traffic.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.